Medicure Inc. (MPH) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Greetings and welcome to Medicare's earnings conference call for the quarter ended September 30th, 2025. My name is Ali and I will be your operator for today's call. At this time, all participants are in a listen-only mode. Before we proceed, I would like to remind everyone that this presentation contains forward-looking statements relating to future results, events, and expectations, which are made pursuant to the Safe Harbors Provision of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, those described in the company's most recent annual information form and form 20F. Later, we will conduct a question and answer session. Please note that this conference call is being recorded and today's date is November 20, 2025. I would now like to turn the conference over to Dr. Albert Friesen, Chief Executive Officer of Medicure Incorporated. Please go ahead, Dr. Friesen. Thank you, Ali, and good morning to all on the call. We appreciate your interest and participation in today's call. Joining me today on the Q3 2025 financial statements call is Dr. Neil Owens, President and Chief Operating Officer, and Haris Uttan, Medicare's Chief Financial Officer. The net revenue for Q3 2025 was 8.2 million, an increase from the previous year, where our net revenue is 5.2, largely due to the addition of two pharmacies. The company recorded a net loss of 1.4 million, or 13 cents per share, compared to a net income of 680,000, or 7 cents per share, for the quarter ending September 30th, 2024. And that loss is about the same as the non-cash items inclu...